The Genetics Podcast
EP 184: Rethinking speed and scale in clinical genomics with Euan Ashley of Stanford University
Apr 24, 2025
Euan Ashley, Chair of the Department of Medicine at Stanford and co-founder of biotech firms, shares insights from his groundbreaking work in ultra-rapid genome sequencing. He highlights a pivotal case of diagnosing a newborn's cardiac condition in just eight hours. Euan discusses the integration of AI and wearables in preventive medicine, as well as the genetics behind elite athletic performance. Additionally, he explores the ethical considerations of widespread genetic testing and the potential of generative AI in developing novel therapies.
42:56
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Euan Ashley's work highlights how ultra-rapid genome sequencing can drastically improve timely medical interventions for critically ill patients.
- The integration of genetic data with wearable technology and AI holds the potential to revolutionize preventive medicine and athletic training.
Deep dives
The Impact of Whole Genome Sequencing
Whole genome sequencing is transforming the field of medical genomics, enabling rapid diagnosis and personalized treatment for genetic diseases. This technology has significantly shortened the time required to sequence and interpret genomes, exemplified by a case where a critically ill infant was diagnosed with long QT syndrome within hours, allowing for timely medical intervention. Rapid sequencing not only enhances patient care but also highlights the importance of high-quality interpretation to inform clinical decisions. As advancements continue, the potential for genome sequencing to become a standard diagnostic tool in medical practice is becoming increasingly evident.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
